• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期急性疟疾时的胎儿和母体血液动力学。

Fetal and maternal hemodynamics in acute malaria during pregnancy.

机构信息

National University of Rwanda, University Teaching Hospital of Kigali, Kigali, Rwanda.

出版信息

Int J Gynaecol Obstet. 2012 Oct;119(1):66-9. doi: 10.1016/j.ijgo.2012.04.024. Epub 2012 Jul 12.

DOI:10.1016/j.ijgo.2012.04.024
PMID:22795756
Abstract

OBJECTIVE

To measure maternal and fetal hemodynamics during acute malaria in pregnancy.

METHODS

Time courses of maternal heart rate (MHR), maternal blood pressure (BP), and fetal heart rate (FHR) were performed until 56 days after initiation of anti-malarial treatment with artemether-lumefantrine. Women with malaria were hospitalized for at least 3 days until recovery.

RESULTS

Mean baseline characteristics of pregnant women with malaria (n=38) versus pregnant women without malaria (n=39) were as follows: gestational age (28.8 vs 24.6 weeks; P=0.006); maximum FHR (165.3 vs 158.3 beats per minute [bpm]; P=0.054); minimum FHR (137.6 vs 128.7 bpm; P=0.016); mean BP (74.7 vs 80.9 mm Hg; P=0.001); pulse pressure (40.3 vs 42.1mm Hg; P=0.300); and MHR (107.4 vs 81.3 bpm; P<0.001). The geometric mean parasite count was 13 795 per μL. Complete time courses were collected from a subgroup of participants. For women with malaria, maternal body temperature and BP normalized within 24 hours and after 72 hours, respectively. The MHR among pregnant women without malaria showed a physiologic increase during pregnancy of approximately 7 bpm between days 0 and 56. The mean FHR among women with malaria normalized after 72 hours.

CONCLUSION

Acute malaria induces maternal and fetal hemodynamic changes.

摘要

目的

测量妊娠合并急性疟疾期间的母婴血液动力学。

方法

在使用青蒿琥酯-咯萘啶抗疟治疗开始后,直至治疗开始后的 56 天,对母亲的心率(MHR)、母亲的血压(BP)和胎儿的心率(FHR)进行时间进程测量。患有疟疾的妇女住院至少 3 天,直到康复。

结果

患有疟疾的孕妇(n=38)与未患疟疾的孕妇(n=39)的基线特征平均值如下:妊娠周数(28.8 对 24.6 周;P=0.006);最大 FHR(165.3 对 158.3 次/分钟[bpm];P=0.054);最小 FHR(137.6 对 128.7 bpm;P=0.016);平均 BP(74.7 对 80.9mmHg;P=0.001);脉压(40.3 对 42.1mm Hg;P=0.300);和 MHR(107.4 对 81.3 bpm;P<0.001)。几何均数寄生虫计数为 13795 每μL。从参与者的一个亚组中收集了完整的时间进程。对于患有疟疾的妇女,体温和血压分别在 24 小时内和 72 小时内恢复正常。未患疟疾的孕妇的 MHR 在妊娠期间的第 0 天至第 56 天之间生理性增加了约 7bpm。患有疟疾的女性的平均 FHR 在 72 小时后恢复正常。

结论

急性疟疾引起母婴血液动力学变化。

相似文献

1
Fetal and maternal hemodynamics in acute malaria during pregnancy.妊娠期急性疟疾时的胎儿和母体血液动力学。
Int J Gynaecol Obstet. 2012 Oct;119(1):66-9. doi: 10.1016/j.ijgo.2012.04.024. Epub 2012 Jul 12.
2
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.青蒿琥酯-阿莫地喹与蒿甲醚-本芴醇治疗妊娠期急性非复杂性疟疾的随机试验。
Int J Gynaecol Obstet. 2015 Oct;131(1):41-4. doi: 10.1016/j.ijgo.2015.05.009. Epub 2015 Jul 3.
3
A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.在乌干达穆拉戈医院进行的一项随机临床试验,比较蒿甲醚-本芴醇与氯胍-氨苯砜治疗妊娠期单纯性疟疾的安全性、临床及寄生虫学反应。
J Infect Dev Ctries. 2008 Apr 1;2(2):135-9.
4
Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.药物遗传学对孕妇血浆中卤泛群药代动力学及疟疾治疗结果的影响。
Malar J. 2017 Jul 3;16(1):267. doi: 10.1186/s12936-017-1914-9.
5
Efficacy and safety of artemehter-lumefantrine in uncomplicated falciparum malaria in Liberia.青蒿琥酯-本芴醇在利比里亚非复杂性恶性疟中的疗效与安全性。
J Pak Med Assoc. 2011 Feb;61(2):131-4.
6
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.蒿甲醚-本芴醇与奎宁治疗无并发症恶性疟原虫疟疾孕妇的疗效和安全性比较:一项开放标签、随机、非劣效性试验。
Lancet Infect Dis. 2010 Nov;10(11):762-9. doi: 10.1016/S1473-3099(10)70202-4.
7
Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh.蒿甲醚-本芴醇治疗孟加拉国非复杂性恶性疟的疗效
Am J Trop Med Hyg. 2007 Jan;76(1):39-41.
8
Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.在非免疫人群中使用蒿甲醚-本芴醇治疗急性非复杂性恶性疟:一项安全性、有效性及药代动力学研究。
Am J Trop Med Hyg. 2008 Feb;78(2):241-7.
9
Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients.恶性疟原虫与曼氏血吸虫合并感染以及蒿甲醚-本芴醇对疟疾患者的附带益处。
J Infect Dev Ctries. 2013 Jun 15;7(6):468-74. doi: 10.3855/jidc.2658.
10
Artemether-lumefantrine: an option for malaria.蒿甲醚-本芴醇:疟疾的一种选择。
Ann Pharmacother. 2012 Apr;46(4):567-77. doi: 10.1345/aph.1Q539. Epub 2012 Apr 10.

引用本文的文献

1
Preclinical Trial of Traditional Plant Remedies for the Treatment of Complications of Gestational Malaria.传统植物疗法治疗妊娠期疟疾并发症的临床前试验
Medicines (Basel). 2021 Dec 17;8(12):79. doi: 10.3390/medicines8120079.
2
Identification of High-Risk Pregnancies in a Remote Setting Using Ambulatory Blood Pressure: The MINDI Cohort.利用动态血压识别偏远地区的高危妊娠:MINDI队列研究
Front Public Health. 2020 Mar 24;8:86. doi: 10.3389/fpubh.2020.00086. eCollection 2020.
3
Comparison on simultaneous caillary and venous parasite density and genotyping results from children and adults with uncomplicated malaria: a prospective observational study in Uganda.
比较儿童和成人无并发症疟疾患者毛细血管和静脉寄生虫密度及基因分型结果:乌干达一项前瞻性观察研究。
BMC Infect Dis. 2019 Jun 26;19(1):559. doi: 10.1186/s12879-019-4174-1.
4
Maternal near miss and mortality in a tertiary care hospital in Rwanda.卢旺达一家三级护理医院的孕产妇严重并发症及死亡情况
BMC Pregnancy Childbirth. 2015 Sep 3;15:203. doi: 10.1186/s12884-015-0619-8.
5
A morphometric and histological study of placental malaria shows significant changes to villous architecture in both Plasmodium falciparum and Plasmodium vivax infection.一项关于胎盘疟疾的形态测量和组织学研究表明,在恶性疟原虫和间日疟原虫感染中,绒毛结构均出现显著变化。
Malar J. 2014 Jan 4;13:4. doi: 10.1186/1475-2875-13-4.